Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
10.1038/nm1201-1291 26 LiD.XueM.GengZ.ChenP
What did they get wrong (or right)
CJC-1295 poses a risk of immunogenicity, a condition in which your body reacts to a protein-based drug as though it were a pathogen.9 In such an event, youd get none of the benefits that CJC-1295 would otherwise offer and could instead suffer a life-threatening allergic response.21 The best way to avoid serious adverse events related to immunogenicity is to undergo a comprehensive medical assessment with a licensed provider knowledgeable in therapeutic peptides and their potential hazards
When to reconstitute a new vial during escalation A 5mg vial at 2.5mg/mL (2mL of water) contains 200 total units of solution
Cao HY, Lian JN, Lin ZS, Zhu ZW, Wang H,Wang HY
